The global contraceptives market is estimated to grow at a CAGR of 6.93% during the forecast years 2019-2027.
The growing awareness for the adoption of contraceptives, rise in the consumption of oral contraceptives to circumvent unwanted pregnancy, an increase in the number of initiatives undertaken by the government and NGOs and growing cognizance about the risk of STIs are the main market drivers for this industry.
However, side-effects linked to contraceptive usage and limited access to contraceptives are some of the restraints that obstruct the growth of the contraceptive market.
Poor healthcare facilities have led to unfulfilled medical demands by the population in developing countries. However, the rise in disposable incomes and technological advancements provide numerous opportunities for contraceptive-manufacturing companies to expand their base into these territories.
Despite all these factors, contraceptives face a lack of acceptance in society owing to certain socio-cultural norms and the conservative mindset of the elderly population in some of the developing countries, which proves to be a hindrance for the market growth.
The global contraceptive market can be classified on the basis of age group, education, drugs & devices and end-users.
The regions that have been analyzed in the global contraceptives market are North America, Europe, Asia-Pacific, Latin America and the Middle East & Africa. The rise in the number of unwanted pregnancies is one of the key reasons for the adoption of contraceptives in the North American region, which is projected to hold the largest market share by 2027.
The upsurge of the contraceptive market in the Europe is due to the introduction of new products and educational initiatives by the government. With the rise in the number of STIs in the Asia-Pacific region, it becomes imperative to adopt contraceptives to maintain sexual health.
Key Topics Covered
1. Contraceptive Market – Summary
2. Industry Outlook
2.1. Market Definition
2.2. Porter’s Five Forces Model
2.2.1. Threat of New Entrants
2.2.2. Threat of Substitute
2.2.3. Bargaining Power of Buyers
2.2.4. Bargaining Power of Suppliers
2.2.5. Threat of Competitive Rivalry
2.3. Regulatory Outlook
2.4. PESTEL Outlook
2.5. Market Attractiveness Index
2.6. Market Player Positioning
2.7. Key Insights
2.7.1. Oral Contraceptive Are the Majorly Used Contraceptive Drugs
2.7.2. Condoms Are the Widely Used Contraceptives Device
2.7.3. Age Group of 15-24 Years Are the Major Revenue Contributors to the Global Contraceptive Market
2.8. Market Drivers
2.8.1. Growing Cognizance for Contraceptives
2.8.2. Increasing Usage of Oral Contraceptives to Evade Unplanned Pregnancy
2.8.3. Surge in the Initiatives of Government & NGO
2.8.4. Growing Awareness About STD
2.9. Market Restraints
2.9.1. Side Effects Restricting the Growth of Contraceptives
2.9.2. Limited Access to Contraceptives
2.10. Market Opportunities
2.10.1. Rising Disposable Income in Emerging Economies
2.10.2. Unmet Medical Needs in the Emerging Economies
2.10.3. Technological Advancements
2.11. Market Challenges
2.11.1. Lack of Acceptance of Society
3. Contraceptive Market Outlook – By Education
3.1. Less Than High School
3.2. High School Graduate
3.3. College Graduate
3.4. Other College Degrees
4. Contraceptive Market Outlook – By Age Group
4.1. 15-24 Years
4.2. 25-34 Years
4.3. 35-44 Years
4.4. Above 44 Years
5. Contraceptive Market Outlook – By End-user
6. Contraceptive Market Outlook – By Drugs & Devices
6.1. Contraceptives Drugs
6.1.1. Oral Contraceptive Pills
6.1.2. Injectable Contraceptives
6.1.3. Topical Contraceptives
6.2. Contraceptive Devices
6.2.1. Male Condoms
6.2.2. Female Condoms
6.2.4. Contraceptive Sponges
6.2.5. Vaginal Rings
6.2.6. Subdermal Implants
6.2.7. Intra-Uterine Devices
184.108.40.206. Copper Intra-Uterine Devices
220.127.116.11. Hormonal Intra-Uterine Devices
7. Contraceptive Market – Regional Outlook
7.1. North America
7.1.1. Market By Education
7.1.2. Market By Age Group
7.1.3. Market By End-user
7.1.4. Market By Drugs & Devices
18.104.22.168. Market By Drugs
22.214.171.124. Market By Devices
7.1.5. Country Analysis
126.96.36.199. United States
7.4. Latin America
7.5. The Middle East and Africa
8. Competitive Landscape
8.1. Company Profiles
8.1.1. Allergan Inc.
8.1.2. Bayer AG
8.1.5. Pfizer Inc.
8.1.6. Church & Dwight Co. Inc.
8.1.7. Afaxys Inc.
8.1.8. Apothecus Pharmaceutical Corporation
8.1.9. Cooper Surgical Inc.
8.1.10. Okamoto Industries Inc.
8.1.11. Mayer Laboratories Inc.
8.1.12. Agile Therapeutics
8.1.13. Merck & Co. Inc.
8.1.14. Reckitt Benckiser PLC
8.1.15. SMB Corporation
8.1.16. Teva Pharmaceutical Industries Ltd.
8.1.17. Ocon Medical Ltd.
For more information about this report visit https://www.researchandmarkets.com/r/ld7tcn